Pre-order Enquiry
Request Free Sample
Global Nicotinamide Mononucleotide (NMN) Market Insights and Forecast to 2027
SKU ID : QYR-18113824 | Publishing Date : 27-Apr-2021 | No. of pages : 111
Request Sample
Request Customization
Check Discounts
Nicotinamide mononucleotide is a nucleotide derived from ribose and nicotinamide. NMN is made from B vitamins in the body, and is a molecule naturally occurring in all life forms.
In the world, North America and China are the major manufacturing regions. China is the market leader in nicotinamide mononucleotide, accounting for 46.41% of the production market by revenue in 2019.
GeneHarbor, Herbalmax, Shinkowa Pharmaceutical, EffePharm and Genex Formulas are the world's leading niacinamide mononucleotide manufacturers. In 2019, GeneHarbor accounted for 41.17% of the global total.
Nicotinamide single nucleotide downstream applications have health care products, cosmetics and so on. Globally, health care products are the largest application market, accounting for 99.74% of the total consumption of nicotinamide mononucleotide in 2019.
North America, Europe and China are the major consumer regions of the global nicotinamide mononucleotide market, among which China is the largest part. In 2019, Chinese consumption accounted for about 67.83% of the total global consumption.
Market Analysis and Insights: Global Nicotinamide Mononucleotide (NMN) Market
The global Nicotinamide Mononucleotide (NMN) market is valued at US$ 98.5 million in 2019. The market size will reach US$ 296.5 million by the end of 2026, growing at a CAGR of 7.3% during 2021-2026.
Global Nicotinamide Mononucleotide (NMN) Scope and Segment
Nicotinamide Mononucleotide (NMN) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nicotinamide Mononucleotide (NMN) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
Content ＜ 98%
Content ≥ 98%
Segment by Application
Health Care Products
Cosmetics
Others
By Company
GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
Bontac
EffePharm
Zhejiang Jiahua Pharmchemical Co., Ltd.
CELFULL
Kindomway
Production by Region
North America
Europe
China
Japan
Hong Kong
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
In the world, North America and China are the major manufacturing regions. China is the market leader in nicotinamide mononucleotide, accounting for 46.41% of the production market by revenue in 2019.
GeneHarbor, Herbalmax, Shinkowa Pharmaceutical, EffePharm and Genex Formulas are the world's leading niacinamide mononucleotide manufacturers. In 2019, GeneHarbor accounted for 41.17% of the global total.
Nicotinamide single nucleotide downstream applications have health care products, cosmetics and so on. Globally, health care products are the largest application market, accounting for 99.74% of the total consumption of nicotinamide mononucleotide in 2019.
North America, Europe and China are the major consumer regions of the global nicotinamide mononucleotide market, among which China is the largest part. In 2019, Chinese consumption accounted for about 67.83% of the total global consumption.
Market Analysis and Insights: Global Nicotinamide Mononucleotide (NMN) Market
The global Nicotinamide Mononucleotide (NMN) market is valued at US$ 98.5 million in 2019. The market size will reach US$ 296.5 million by the end of 2026, growing at a CAGR of 7.3% during 2021-2026.
Global Nicotinamide Mononucleotide (NMN) Scope and Segment
Nicotinamide Mononucleotide (NMN) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nicotinamide Mononucleotide (NMN) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
Content ＜ 98%
Content ≥ 98%
Segment by Application
Health Care Products
Cosmetics
Others
By Company
GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
Bontac
EffePharm
Zhejiang Jiahua Pharmchemical Co., Ltd.
CELFULL
Kindomway
Production by Region
North America
Europe
China
Japan
Hong Kong
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
